Variant report

Variant	nsv1010919
Chromosome Location	chr1:211804252-211823073
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:853)
CpG islands
(count:61)
Chromatin interactive
region (count:29)
LncRNA
region (count:9)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:853 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr1:211821401-211822092	HepG2	liver:	n/a	n/a
2	ARID3A	chr1:211809641-211809646	HepG2	liver:	n/a	n/a
3	ARID3A	chr1:211804199-211804552	K562	blood:	n/a	n/a
4	ARID3A	chr1:211822377-211822686	HepG2	liver:	n/a	n/a
5	ARID3A	chr1:211813573-211813821	HepG2	liver:	n/a	n/a
6	ATF1	chr1:211804153-211804664	K562	blood:	n/a	n/a
7	BACH1	chr1:211804337-211804569	K562	blood:	n/a	n/a
8	BACH1	chr1:211817401-211817500	K562	blood:	n/a	n/a
9	BHLHE40	chr1:211816556-211817005	HepG2	liver:	n/a	n/a
10	BHLHE40	chr1:211806439-211807015	K562	blood:	n/a	n/a
11	BHLHE40	chr1:211821516-211822044	HepG2	liver:	n/a	n/a
12	BHLHE40	chr1:211821644-211822015	K562	blood:	n/a	n/a
13	BHLHE40	chr1:211809895-211810193	HepG2	liver:	n/a	n/a
14	BHLHE40	chr1:211803449-211804523	K562	blood:	n/a	n/a
15	BHLHE40	chr1:211804930-211805000	K562	blood:	n/a	n/a
16	BRCA1	chr1:211811977-211812437	Hela-S3	cervix:	n/a	n/a
17	BRCA1	chr1:211809716-211810246	Hela-S3	cervix:	n/a	n/a
18	BRCA1	chr1:211812819-211813935	Hela-S3	cervix:	n/a	n/a
19	BRCA1	chr1:211817321-211817495	HepG2	liver:	n/a	n/a
20	BRCA1	chr1:211817084-211817649	Hela-S3	cervix:	n/a	n/a
21	CBX3	chr1:211803310-211804825	K562	blood:	n/a	n/a
22	CBX3	chr1:211817276-211817626	K562	blood:	n/a	n/a
23	CCNT2	chr1:211803475-211804494	K562	blood:	n/a	chr1:211804097-211804106 chr1:211804102-211804111 chr1:211803753-211803773
24	CEBPB	chr1:211816722-211817561	Hela-S3	cervix:	n/a	n/a
25	CEBPB	chr1:211812863-211813645	IMR90	lung:	n/a	n/a
26	CEBPB	chr1:211814469-211814641	Hela-S3	cervix:	n/a	chr1:211814555-211814566
27	CEBPB	chr1:211809083-211809560	Hela-S3	cervix:	n/a	n/a
28	CEBPB	chr1:211814534-211814619	A549	lung:	n/a	chr1:211814555-211814566
29	CEBPB	chr1:211816632-211816911	HepG2	liver:	n/a	n/a
30	CEBPB	chr1:211815035-211815128	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr1:211821646-211821965	HepG2	liver:	n/a	n/a
32	CEBPB	chr1:211811877-211813893	Hela-S3	cervix:	n/a	n/a
33	CEBPB	chr1:211820660-211821118	Hela-S3	cervix:	n/a	n/a
34	CEBPB	chr1:211816648-211816815	HepG2	liver:	n/a	n/a
35	CEBPB	chr1:211816547-211816869	HepG2	liver:	n/a	n/a
36	CEBPB	chr1:211807074-211807099	K562	blood:	n/a	n/a
37	CEBPB	chr1:211809821-211810270	Hela-S3	cervix:	n/a	n/a
38	CEBPB	chr1:211813455-211813647	HepG2	liver:	n/a	n/a
39	CEBPB	chr1:211814413-211814712	HepG2	liver:	n/a	chr1:211814555-211814566
40	CEBPB	chr1:211821597-211822034	Hela-S3	cervix:	n/a	n/a
41	CEBPB	chr1:211809165-211809572	IMR90	lung:	n/a	n/a
42	CEBPB	chr1:211809217-211809545	A549	lung:	n/a	n/a
43	CEBPD	chr1:211803419-211804603	K562	blood:	n/a	n/a
44	CEBPD	chr1:211804062-211804591	K562	blood:	n/a	n/a
45	CEBPD	chr1:211816616-211817030	HepG2	liver:	n/a	n/a
46	CEBPZ	chr1:211808558-211808673	HepG2	liver:	n/a	n/a
47	CHD1	chr1:211822469-211822827	IMR90	lung:	n/a	n/a
48	CHD2	chr1:211806453-211806801	K562	blood:	n/a	n/a
49	CHD2	chr1:211816797-211817575	Hela-S3	cervix:	n/a	n/a
50	CHD2	chr1:211803522-211804419	K562	blood:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr1:211816097-211816147	AG09319	gingival:	n/a
2	chr1:211816097-211816147	HepG2	liver:	n/a
3	chr1:211816097-211816147	AG09309	skin:	n/a
4	chr1:211816097-211816147	HL-60	blood:	n/a
5	chr1:211816097-211816147	LNCaP	prostate:	n/a
6	chr1:211816097-211816147	HIPEpiC	eye:	n/a
7	chr1:211816097-211816147	T-47D	breast:	n/a
8	chr1:211816097-211816147	PFSK-1	brain:	n/a
9	chr1:211816097-211816147	SK-N-MC	brain:	n/a
10	chr1:211816097-211816147	RPTEC	kidney:	n/a
11	chr1:211816097-211816147	NT2-D1	testis:	n/a
12	chr1:211816097-211816147	HCF	heart:	n/a
13	chr1:211816097-211816147	HCPEpiC	choroid plexus:	n/a
14	chr1:211816097-211816147	HEEpiC	esophagus:	n/a
15	chr1:211816097-211816147	HMEC	breast:	n/a
16	chr1:211816097-211816147	HAEpiC	amniotic membrane:	n/a
17	chr1:211816097-211816147	NHBE	bronchial:	n/a
18	chr1:211816097-211816147	Caco-2	colon:	n/a
19	chr1:211816097-211816147	IMR90	lung:	fetal
20	chr1:211816097-211816147	A549	lung:	n/a
21	chr1:211816097-211816147	U87	brain:	n/a
22	chr1:211816097-211816147	NB4	blood:	n/a
23	chr1:211816097-211816147	K562	blood:	n/a
24	chr1:211816097-211816147	HCM	heart:	n/a
25	chr1:211816097-211816147	HUVEC	blood vessel:	n/a
26	chr1:211816097-211816147	SK-N-SH	brain:	n/a
27	chr1:211816097-211816147	GM12892	blood:	n/a
28	chr1:211816097-211816147	HCT-116	colon:	n/a
29	chr1:211816097-211816147	GM12891	blood:	n/a
30	chr1:211816097-211816147	H1-hESC	embryonic stem cell:	embryo
31	chr1:211816097-211816147	MCF-7	breast:	n/a
32	chr1:211816097-211816147	NH-A	brain:	n/a
33	chr1:211816097-211816147	HEK293	kidney:	embryo
34	chr1:211816097-211816147	HNPCEpiC	eye:	n/a
35	chr1:211816097-211816147	GM06990	blood:	n/a
36	chr1:211816097-211816147	CMK	blood:	n/a
37	chr1:211816097-211816147	AG04450	lung:	fetal
38	chr1:211816097-211816147	GM19239	blood:	n/a
39	chr1:211816097-211816147	ECC-1	luminal epithelium:	n/a
40	chr1:211816097-211816147	PrEC	prostate:	n/a
41	chr1:211816097-211816147	MCF10A-Er-Src	breast:	n/a
42	chr1:211816097-211816147	Jurkat	blood:	n/a
43	chr1:211816097-211816147	SKMC	muscle:	n/a
44	chr1:211816097-211816147	AG04449	skin:	fetal
45	chr1:211816097-211816147	Hela-S3	cervix:	n/a
46	chr1:211816097-211816147	NHDF-neo	bronchial:	n/a
47	chr1:211816097-211816147	HRE	kidney:	n/a
48	chr1:211816097-211816147	PANC-1	pancreas:	n/a
49	chr1:211816097-211816147	SAEC	small airway:	n/a
50	chr1:211816097-211816147	BE2_C	brain:	n/a

(count:29 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr1:211788189..211791176-chr1:211807791..211810721,2	MCF-7	breast:
2	chr1:211793145..211800078-chr1:211800841..211805263,11	K562	blood:
3	chr1:211749200..211754595-chr1:211816014..211824648,8	K562	blood:
4	chr1:211741510..211743942-chr1:211802313..211805190,2	K562	blood:
5	chr1:211750037..211752864-chr1:211820167..211823136,4	MCF-7	breast:
6	chr1:211804616..211806935-chr1:211847772..211850584,2	K562	blood:
7	chr1:211750004..211752900-chr1:211803932..211806097,2	MCF-7	breast:
8	chr1:211794683..211796296-chr1:211806280..211809015,2	MCF-7	breast:
9	chr1:211723836..211726328-chr1:211802302..211805262,2	K562	blood:
10	chr1:211750794..211754252-chr1:211815868..211819773,4	MCF-7	breast:
11	chr1:211808019..211810498-chr1:211819976..211822363,2	K562	blood:
12	chr1:211808019..211810498-chr1:211819976..211822363,2	K562	blood:
13	chr1:211747427..211749600-chr1:211810215..211812897,2	K562	blood:
14	chr1:211664330..211664868-chr1:211821407..211821972,2	K562	blood:
15	chr1:211782443..211790536-chr1:211800686..211806134,8	K562	blood:
16	chr1:211820504..211824177-chr1:211831233..211834573,3	MCF-7	breast:
17	chr1:211805954..211807830-chr1:211810555..211812059,2	K562	blood:
18	chr1:211816612..211818942-chr1:211819387..211821012,2	MCF-7	breast:
19	chr1:211656368..211658461-chr1:211818304..211819839,2	K562	blood:
20	chr1:211751483..211753774-chr1:211805908..211807801,3	MCF-7	breast:
21	chr1:211805954..211807830-chr1:211810555..211812059,2	K562	blood:
22	chr1:211781693..211784457-chr1:211822859..211825401,2	K562	blood:
23	chr1:211816134..211817787-chr1:211819701..211822516,2	K562	blood:
24	chr1:211751888..211754442-chr1:211802354..211807016,4	K562	blood:
25	chr1:211807063..211809288-chr1:211816053..211818328,2	K562	blood:
26	chr1:211819966..211822371-chr1:211824422..211826209,2	K562	blood:
27	chr1:211805499..211810389-chr1:211816053..211819078,4	K562	blood:
28	chr1:211802788..211806999-chr1:211814684..211819078,4	K562	blood:
29	chr1:211816612..211818942-chr1:211819387..211821012,2	MCF-7	breast:

(count:9 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TRAF5-4	chr1:211816165-211816209	XLOC_000549
2	lnc-TRAF5-4	chr1:211809248-211809787	XLOC_000549
3	lnc-TRAF5-5	chr1:211813037-211813702	ENSG00000227764
4	lnc-TRAF5-5	chr1:211813314-211814173	NONHSAT009306
5	lnc-TRAF5-5	chr1:211813005-211813231	NONHSAT009306
6	lnc-TRAF5-5	chr1:211813150-211813231	ENSG00000227764
7	lnc-NEK2-1	chr1:211816165-211816209	ENSG00000228792.2
8	lnc-TRAF5-5	chr1:211813561-211813702	ENSG00000227764
9	lnc-NEK2-1	chr1:211809248-211809787	ENSG00000228792.2

No data

Variant related genes	Relation type
ENSG00000228792	TF binding region
ENSG00000227764	TF binding region
ENSG00000228792	CpG island
ENSG00000227764	CpG island
ENSG00000170385	chromatin interactions
ENSG00000231057	chromatin interactions
ENSG00000117650	chromatin interactions
ENSG00000228792	chromatin interactions
MLL	miRNA target sites
TSPAN14	miRNA target sites
CTSA	miRNA target sites
SLC10A7	miRNA target sites

Extended variants
information (count: 774 )
Associated
traits (count: 89 )

Variant overlapped rSNPs/rCNVs (count:774 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs116192616	chr1:211804303-211804304	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs559573572	chr1:211804341-211804342	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs185881238	chr1:211804371-211804372	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs545264130	chr1:211804386-211804387	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs190337912	chr1:211804394-211804395	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs531184839	chr1:211804401-211804402	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs549009202	chr1:211804435-211804436	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs528337670	chr1:211804491-211804492	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs528070531	chr1:211804545-211804546	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs546708600	chr1:211804567-211804568	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs571243482	chr1:211804574-211804575	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs538871077	chr1:211804583-211804584	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs144023196	chr1:211804619-211804620	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs147302904	chr1:211804646-211804647	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs116059412	chr1:211804670-211804671	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs6702422	chr1:211804675-211804676	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs7523748	chr1:211804676-211804677	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
18	rs181513698	chr1:211804679-211804680	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs547115780	chr1:211804701-211804702	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs568600178	chr1:211804759-211804760	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs545587521	chr1:211804793-211804794	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs563690430	chr1:211804800-211804801	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs576023597	chr1:211804816-211804817	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs543371128	chr1:211804868-211804869	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs561569845	chr1:211804919-211804920	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs140890117	chr1:211804923-211804924	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs528131946	chr1:211804926-211804927	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs6540696	chr1:211804952-211804953	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs4951416	chr1:211804984-211804985	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs532067851	chr1:211805055-211805056	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs4951417	chr1:211805093-211805094	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs373298382	chr1:211805117-211805118	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs4951418	chr1:211805154-211805155	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs114971797	chr1:211805181-211805182	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs187661312	chr1:211805230-211805231	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs535066040	chr1:211805241-211805242	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs4951419	chr1:211805261-211805262	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs578057533	chr1:211805306-211805307	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
39	rs191888506	chr1:211805309-211805310	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
40	rs552571646	chr1:211805321-211805322	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs182976952	chr1:211805327-211805328	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs575944761	chr1:211805328-211805329	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs187479046	chr1:211805345-211805346	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs555347167	chr1:211805409-211805410	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs573528187	chr1:211805458-211805459	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs540230155	chr1:211805467-211805468	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs548406484	chr1:211805495-211805496	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs564689557	chr1:211805512-211805513	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs374616618	chr1:211805513-211805514	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs4951420	chr1:211805625-211805626	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:89)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Autism	22495311	CNVD
Liposarcoma	21253554	CNVD
Burkitt''s lymphoma	18698080	CNVD
Melanoma	18172304	CNVD
Rett syndrome	21593744	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Neuroblastoma	21899760	CNVD
Glioblastoma multiforme	17002787	CNVD
Breast cancer	21858162	CNVD
Non-small cell lung cancer	21385341	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	21509527	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17393978	CNVD
Hepatocellular carcinoma	16750200	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Trisomy 5 syndrome	21098271	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Chordoma	18071362	CNVD
Macular degeneration	22558131	CNVD
Alzheimer''s disease	21403675	CNVD
Multiple myeloma	16461302	CNVD
van der Woude syndrome	22470819	CNVD
van der Woude syndrome	20818247	CNVD
T-cell lymphomas	19863542	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	17060936	CNVD
Atypical hemolytic uremic syndrome	19861685	CNVD
Hepatocellular carcinoma	18803288	CNVD
Urothelial tumor	18831757	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21720365	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Medulloblastoma	16783165	CNVD

Chromatin state (count:534 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:211800000-211807200	Enhancers	Fetal Heart	heart
2	chr1:211802000-211806400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
3	chr1:211803000-211804800	Enhancers	Fetal Intestine Small	intestine
4	chr1:211803400-211804800	Enhancers	Fetal Intestine Large	intestine
5	chr1:211803400-211804800	Enhancers	Placenta	Placenta
6	chr1:211803400-211804800	Flanking Active TSS	K562	blood
7	chr1:211803400-211805000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
8	chr1:211803400-211805000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
9	chr1:211803400-211806000	Enhancers	Breast Myoepithelial Primary Cells	Breast
10	chr1:211803400-211807000	Enhancers	Ovary	ovary
11	chr1:211803400-211807600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
12	chr1:211803400-211807600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
13	chr1:211803600-211804400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr1:211803600-211804400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
15	chr1:211803600-211804800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr1:211803600-211805000	Enhancers	Fetal Lung	lung
17	chr1:211803600-211807200	Enhancers	Fetal Muscle Trunk	muscle
18	chr1:211803600-211807200	Enhancers	Fetal Muscle Leg	muscle
19	chr1:211803800-211807600	Enhancers	Fetal Thymus	thymus
20	chr1:211804000-211804400	Flanking Active TSS	Spleen	Spleen
21	chr1:211804000-211804400	Flanking Active TSS	Hela-S3	cervix
22	chr1:211804000-211804400	Flanking Bivalent TSS/Enh	NHEK	skin
23	chr1:211804000-211805000	Enhancers	ES-I3 Cell Line	embryonic stem cell
24	chr1:211804000-211805000	Enhancers	HUES6 Cell Line	embryonic stem cell
25	chr1:211804000-211805600	Weak transcription	HMEC	breast
26	chr1:211804000-211806400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
27	chr1:211804000-211806400	Weak transcription	Gastric	stomach
28	chr1:211804000-211806800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
29	chr1:211804200-211804400	Enhancers	Primary hematopoietic stem cells	blood
30	chr1:211804200-211804800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
31	chr1:211804200-211804800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr1:211804200-211804800	Enhancers	Adipose Nuclei	Adipose
33	chr1:211804200-211804800	Bivalent Enhancer	HepG2	liver
34	chr1:211804200-211805600	Weak transcription	Esophagus	oesophagus
35	chr1:211804200-211805600	Weak transcription	NH-A	brain
36	chr1:211804200-211805800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
37	chr1:211804200-211805800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
38	chr1:211804200-211806400	Weak transcription	A549	lung
39	chr1:211804200-211807200	Enhancers	Right Atrium	heart
40	chr1:211804200-211807200	Enhancers	Right Ventricle	heart
41	chr1:211804200-211807600	Enhancers	Left Ventricle	heart
42	chr1:211804200-211813400	Weak transcription	H1 Cell Line	embryonic stem cell
43	chr1:211804200-211816600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
44	chr1:211804400-211804600	Enhancers	Colon Smooth Muscle	Colon
45	chr1:211804400-211805200	Bivalent Enhancer	NHEK	skin
46	chr1:211804400-211805400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
47	chr1:211804400-211805800	Weak transcription	Primary hematopoietic stem cells	blood
48	chr1:211804400-211805800	Weak transcription	Lung	lung
49	chr1:211804400-211806200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr1:211804400-211806200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links